シナプスMunc13-1の喪失は,脊髄筋縮における神経伝達異常の根底にある
Mehri Moradi1, Chunchu Deng1,2, Michael Sendtner3
1Institute of Clinical Neurobiology, University Hospital Wuerzburg, Versbacher Str. 5, 97078, Wuerzburg, Germany.
Cellular and molecular life sciences : CMLS
|August 29, 2025
まとめ
脊髄筋縮 (SMA) はシナプス喪失を伴う. Munc13-1タンパク質は,その軸索輸送はSmnに依存し,神経機能に影響するので,SMAにおけるシナプスの完全性にとって極めて重要です.
科学分野:
- 神経科学
- 分子生物学
- 遺伝学
背景:
- 脊髄筋縮 (SMA) は神経変性疾患で,モトニューロンの変性,筋縮,シナプス喪失を引き起こす.
- SMNタンパク質は,mRNA処理,軸索輸送,および局所翻訳に不可欠であり,シナプスの完全性を維持します.
- Munc13タンパク質は,電圧ゲートされたCa2+チャネル (VGCC) で神経伝達物質の放出を調節する重要な活性ゾーン成分です.
研究 の 目的:
- SMAに関連するシナプス機能障害におけるMunc13タンパク質の役割を調査する.
- SMAに関連するシナプス変異に関与する特定のMunc13ファミリーメンバーを決定する.
主な方法:
- SMAモデルにおけるMunc13-1とMunc13-2の発現と局所化の分析
- Munc13-1 mRNAのアクソナル輸送のSmnへの依存性を調査する.
- モトニューロンにおけるアクティブゾーンアセンブリとVGCCクラスタリングに対するMunc13-1障害の影響を評価する.
主要な成果:
- Munc13-2ではなく,Munc13-1の喪失は,SMAにおけるシナプス異常と相関しています.
- SmnはMunc13-1 mRNAのアクソナル局所化に必要である.
- Munc13-1の局所化が妨げられ,活性ゾーン集合とVGCCのクラスタリングが妨げられ,神経細胞の活性が低下する.
結論:
- Munc13-1は,SMAにおけるシナプスの整合性を維持する上で重要な役割を果たします.
- Munc13- 1を標的とした治療戦略は,SMA患者のシナプス喪失を緩和する可能性がある.
さらに関連する動画
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
2.7K
09:07Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles
Published on: September 25, 2015
21.4K
関連する概念動画
01:26Chemical Synapses
9.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.1K
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
01:28Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
01:20Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
01:29Neuromuscular Junction And Blockade
3.6K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.6K